SCHEDULE 13G 0001674546 XXXXXXXX LIVE Common Stock 06/01/2025 0001125345 MacroGenics, Inc. 556099109 9704 Medical Center Drive Rockville MD 20850 Rule 13d-1(b) Bellevue Group AG a V8 0.00 9929963.00 0.00 9929963.00 9929963.00 N 15.7 HC CO Bellevue Asset Management AG a V8 0.00 9929963.00 0.00 9929963.00 9929963.00 N 15.7 CO MacroGenics, Inc. 9704 Medical Center Drive Rockville, MD, 20850 Bellevue Group AG ("Bellevue") on behalf of its wholly-owned subsidiary, Bellevue Asset Management AG ("BAM AG") Bellevue: Theaterstrasse 12, Zurich, Switzerland, CH-8001 BAM AG: Theaterstrasse 12, Zurich, Switzerland, CH-8001 Bellevue: Switzerland BAM AG: Switzerland N FI Swiss Financial Market Supervisory Authority (FINMA) 9,929,963 15.7% 0 9,929,963 0 9,929,963 Y Y N This statement is filed jointly by Bellevue and BAM AG. BAM AG is a wholly-owned subsidiary of Bellevue. Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Bellevue Group AG /s/ Stefano Montalbano 07/07/2025 /s/ Christoph Eisenring 07/07/2025 Bellevue Asset Management AG /s/ Christoph Eisenring 07/07/2025 /s/ Ivo Betschart 07/07/2025